INVITAE/UnitedHealthcare

2019년 9월 10일

Hi guys,

• Invitae is a leader in advanced medical genetics.
  
  • UnitedHealthcare created a "Preferred Laboratory Network (PLN)".Invitae has been selected as one of the seven lab companies.
    
    Long:
    • LMT 1- 18.9$ (25 % of the planned investment amount)
      
      • LMT 2- 17.34$ (55 % of the planned investment amount)
        
        • LMT 3- 14.79$ (20 % of the planned investment amount)
          TP:30$
          
          Comments and likes are greatly appreciated.
          
          
          I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.